Kampanjeplan Sandoz Group AG
Avansert tidsplan
Enkel graf
Om selskapet Sandoz Group AG
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.| Industry | Pharmaceuticals |
|---|---|
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Дивиденд ао | 0.498 |
| Сайт | https://www.sandoz.com |
| Цена ао | 34.6 |
| Prisendring per dag: | -1.46% (41.71) |
|---|---|
| Prisendring per uke: | -1.2% (41.6) |
| Prisendring per måned: | -10.55% (45.95) |
| Prisendring over 3 måneder: | -1.21% (41.605) |
| Prisendring over seks måneder: | +14.68% (35.84) |
| Prisendring per år: | +31.2% (31.327) |
| Prisendring over 3 år: | 0% (41.1) |
| Prisendring over 5 år: | 0% (41.1) |
| Prisendring over 10 år: | 0% (41.1) |
| Prisendring siden begynnelsen av året: | -9.71% (45.52) |
|
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
|||||||||||||||||||||||||||||||||||||
| Utbytte, % | Utbytte | Basert på resultatene fra perioden | Kjøp før | Utløpsdato for registeret | Utbetaling før |
|---|---|---|---|---|---|
| 0.87% | 0.3 | I кв. 2024 | 01.05.2024 | 03.05.2024 | 20.05.2024 |
| Institusjoner | Volum | Dele, % |
|---|---|---|
| Fisher Asset Management, LLC | 55602 | 0.01 |
| Mengis Capital Management, Inc. | 15328 | 0 |
| Douglas Lane & Associates, LLC | 13802 | 0 |
| Beddow Capital Management Inc | 13293 | 0 |
| Beach Investment Counsel Inc/pa | 7549 | 0 |
| Yousif Capital Management, LLC | 7528 | 0 |
| Bartlett & Co. | 6963 | 0 |
| Patten & Patten, Inc. | 6527 | 0 |
| Bristol John W & Co Inc /NY/ | 5264 | 0 |
| Boit C F David | 2560 | 0 |
| Veileder | Stillingstittel | Betaling | Fødselsår |
|---|---|---|---|
| Mr. Richard Saynor | Chief Executive Officer | N/A | 1967 (58 år) |
| Mr. Asaf Gal | Chief Technology Officer | N/A | 1969 (56 år) |
| Ms. Karen M. King | Head Global Investor Relations | N/A | |
| Ms. Ingrid Sollerer | General Counsel & Chief Compliance Officer | N/A | 1974 (51 år) |
| Ms. Tripti Jha | Chief People Officer | N/A | 1977 (48 år) |
| Mr. Francisco Ballester | President of International | N/A | 1961 (64 år) |
| Mr. Pierre Bourdage | Chief Commercial Officer | N/A | 1979 (46 år) |
| Dr. Glenn A. Gerecke Ph.D. | Chief Manufacturing & Supply Officer | N/A | 1959 (66 år) |
| Mr. Remco J. Steenbergen | Chief Financial Officer | 1968 (57 år) | |
| Ms. Claire D'Abreu-Hayling | Chief Scientific Officer | 1964 (61 år) |
Adresse: Switzerland, Rotkreuz, Suurstoffi 14 - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.sandoz.com
Nettsted: https://www.sandoz.com
